Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Molecular Profile | SRC positive |
| Therapy | Radiotherapy + Si306 |
| Indication/Tumor Type | glioblastoma |
| Response Type | sensitive |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| SRC positive | glioblastoma | sensitive | Radiotherapy + Si306 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, Si306 in combination with radiotherapy decreased growth of radiotherapy-sensitive SRC-positive glioblastoma cells in culture and decreased tumor growth in cell line xenograft models, with increased efficacy compared to Si306 or radiotherapy alone (PMID: 27196762). | 27196762 |
| PubMed Id | Reference Title | Details |
|---|---|---|
| (27196762) | Suppression of SRC Signaling Is Effective in Reducing Synergy between Glioblastoma and Stromal Cells. | Full reference... |